Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,626,749 papers from all fields of science
Search
Sign In
Create Free Account
NV1020
A genetically engineered oncolytic virus with potential antineoplastic property. NV1020 is constructed from the herpes simplex virus 1 (HSV-1) by the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Simplexvirus
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
CT and FDG PET/CT evaluation of response to NV1020 for liver colorectal metastases
A. Iagaru
,
D. Sze
,
S. Gambhir
2009
Corpus ID: 68203073
2008
2008
Imaging characteristics and response after intraarterial administration of the oncolytic herpes virus NV1020 to treat hepatic colorectal metastases
D. Sze
,
S. Gambhir
,
+6 authors
K. Tanabe
2008
Corpus ID: 78555984
15121 Background: Tumor response to oncolytic viruses may show atypical imaging characteristics compared with other agents…
Expand
2008
2008
Tumor efficacy of an oncolytic herpes simplex virus (NV1020) in patients with colorectal cancer metastatic to liver (mCRC)
R. Chari
,
S. Gambhir
,
+7 authors
K. Tanabe
2008
Corpus ID: 74400852
15014 Background: Dose-finding safety results are published for NV1020, a genetically engineered oncolytic Herpes simplex virus…
Expand
2006
2006
APhase I Study of OncoVEX, a Second-Generation Oncolytic Herpes SimplexVirus Expressing Granulocyte Macrophage Colony-Stimulating Factor
J. Hu
,
R. Coffin
,
+17 authors
R. Coombes
2006
Corpus ID: 29147585
Purpose:To conduct a phase I clinical trial with a second-generation oncolytic herpes simplex virus (HSV) expressing granulocyte…
Expand